Variant report

Variant	esv3439256
Chromosome Location	chr19:43065661-43098816
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:43071213-43071350	K562	blood:	n/a	n/a
2	ATF1	chr19:43071854-43072090	K562	blood:	n/a	n/a
3	BACH1	chr19:43073712-43073803	K562	blood:	n/a	n/a
4	BACH1	chr19:43082922-43083098	K562	blood:	n/a	n/a
5	BHLHE40	chr19:43071110-43071282	HepG2	liver:	n/a	n/a
6	BHLHE40	chr19:43071184-43071299	K562	blood:	n/a	n/a
7	BHLHE40	chr19:43067557-43067815	GM12878	blood:	n/a	n/a
8	CEBPB	chr19:43098008-43098186	IMR90	lung:	n/a	chr19:43098079-43098092 chr19:43098079-43098090
9	CEBPB	chr19:43067452-43067756	K562	blood:	n/a	n/a
10	CEBPB	chr19:43097951-43098246	HepG2	liver:	n/a	chr19:43098079-43098092 chr19:43098079-43098090
11	CEBPB	chr19:43071048-43071255	Hela-S3	cervix:	n/a	chr19:43071104-43071117
12	CEBPB	chr19:43097979-43098209	K562	blood:	n/a	chr19:43098079-43098092 chr19:43098079-43098090
13	CEBPB	chr19:43097919-43098273	A549	lung:	n/a	chr19:43098079-43098092 chr19:43098079-43098090
14	CEBPB	chr19:43067439-43067765	A549	lung:	n/a	n/a
15	CEBPB	chr19:43075958-43076158	A549	lung:	n/a	chr19:43076033-43076044
16	CEBPB	chr19:43076011-43076056	HepG2	liver:	n/a	chr19:43076033-43076044
17	CHD2	chr19:43067303-43067400	K562	blood:	n/a	n/a
18	CTCF	chr19:43070580-43070730	HEEpiC	esophagus:	n/a	n/a
19	CTCF	chr19:43071160-43071310	NHEK	skin:	n/a	chr19:43071281-43071294 chr19:43071278-43071296 chr19:43071279-43071295 chr19:43071280-43071301
20	CTCF	chr19:43067594-43067811	GM19239	blood:	n/a	n/a
21	CTCF	chr19:43065840-43065990	HBMEC	blood vessel:	n/a	n/a
22	CTCF	chr19:43065800-43065950	HCT-116	colon:	n/a	n/a
23	CTCF	chr19:43071160-43071310	NHDF-neo	bronchial:	n/a	chr19:43071281-43071294 chr19:43071278-43071296 chr19:43071279-43071295 chr19:43071280-43071301
24	CTCF	chr19:43071160-43071310	GM12875	blood:	n/a	chr19:43071281-43071294 chr19:43071278-43071296 chr19:43071279-43071295 chr19:43071280-43071301
25	CTCF	chr19:43071042-43071462	HCT-116	colon:	n/a	chr19:43071281-43071294 chr19:43071278-43071296 chr19:43071279-43071295 chr19:43071280-43071301
26	CTCF	chr19:43067620-43067770	SAEC	small airway:	n/a	n/a
27	CTCF	chr19:43067580-43067730	HVMF	connective:	n/a	n/a
28	CTCF	chr19:43067568-43067805	GM10266	blood:	n/a	n/a
29	CTCF	chr19:43071180-43071330	HRPEpiC	eye:	n/a	chr19:43071281-43071294 chr19:43071278-43071296 chr19:43071279-43071295 chr19:43071280-43071301
30	CTCF	chr19:43067635-43067811	H1-hESC	embryonic stem cell:	n/a	n/a
31	CTCF	chr19:43071160-43071310	HEEpiC	esophagus:	n/a	chr19:43071281-43071294 chr19:43071278-43071296 chr19:43071279-43071295 chr19:43071280-43071301
32	CTCF	chr19:43067600-43067750	HFF-Myc	foreskin:	n/a	n/a
33	CTCF	chr19:43067600-43067750	HCM	heart:	n/a	n/a
34	CTCF	chr19:43071440-43071590	AG09319	gingival:	n/a	n/a
35	CTCF	chr19:43067480-43067630	HFF	foreskin:	n/a	n/a
36	CTCF	chr19:43071160-43071310	AG09319	gingival:	n/a	chr19:43071281-43071294 chr19:43071278-43071296 chr19:43071279-43071295 chr19:43071280-43071301
37	CTCF	chr19:43071173-43071383	LNCaP	prostate:	n/a	chr19:43071281-43071294 chr19:43071278-43071296 chr19:43071279-43071295 chr19:43071280-43071301
38	CTCF	chr19:43065803-43065978	MCF-7	breast:	n/a	n/a
39	CTCF	chr19:43067640-43067790	NHLF	lung:	n/a	n/a
40	CTCF	chr19:43071160-43071310	WI-38	lung:	n/a	chr19:43071281-43071294 chr19:43071278-43071296 chr19:43071279-43071295 chr19:43071280-43071301
41	CTCF	chr19:43065777-43066005	MCF-7	breast:	n/a	n/a
42	CTCF	chr19:43067600-43067750	GM12864	blood:	n/a	n/a
43	CTCF	chr19:43067458-43067962	A549	lung:	n/a	n/a
44	CTCF	chr19:43071180-43071330	AG09319	gingival:	n/a	chr19:43071281-43071294 chr19:43071278-43071296 chr19:43071279-43071295 chr19:43071280-43071301
45	CTCF	chr19:43067559-43067825	Pancreas_OC	pancreas:	n/a	n/a
46	CTCF	chr19:43094386-43094425	H1-hESC	embryonic stem cell:	n/a	n/a
47	CTCF	chr19:43067640-43067790	GM12867	blood:	n/a	n/a
48	CTCF	chr19:43067600-43067750	GM12869	blood:	n/a	n/a
49	CTCF	chr19:43065804-43065974	GM19240	blood:	n/a	n/a
50	CTCF	chr19:43067660-43067810	NHEK	skin:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:43085416-43085466	ProgFib	skin:	n/a
2	chr19:43085416-43085466	NH-A	brain:	n/a
3	chr19:43085416-43085466	HRE	kidney:	n/a
4	chr19:43085416-43085466	Caco-2	colon:	n/a
5	chr19:43085416-43085466	HPAEpiC	pulmonary alveolar:	n/a
6	chr19:43085416-43085466	GM12892	blood:	n/a
7	chr19:43085416-43085466	Hela-S3	cervix:	n/a
8	chr19:43085416-43085466	HRPEpiC	eye:	n/a
9	chr19:43085416-43085466	SKMC	muscle:	n/a
10	chr19:43085416-43085466	HCF	heart:	n/a
11	chr19:43085416-43085466	HCT-116	colon:	n/a
12	chr19:43085416-43085466	GM12891	blood:	n/a
13	chr19:43085416-43085466	NT2-D1	testis:	n/a
14	chr19:43085416-43085466	AG09319	gingival:	n/a
15	chr19:43085416-43085466	BJ	skin:	n/a
16	chr19:43085416-43085466	AG09309	skin:	n/a
17	chr19:43085416-43085466	NHBE	bronchial:	n/a
18	chr19:43085416-43085466	GM19239	blood:	n/a
19	chr19:43085416-43085466	U87	brain:	n/a
20	chr19:43085416-43085466	RPTEC	kidney:	n/a
21	chr19:43085416-43085466	HUVEC	blood vessel:	n/a
22	chr19:43085416-43085466	AG04450	lung:	fetal
23	chr19:43085416-43085466	Jurkat	blood:	n/a
24	chr19:43085416-43085466	NHDF-neo	bronchial:	n/a
25	chr19:43085416-43085466	HMEC	breast:	n/a
26	chr19:43085416-43085466	PFSK-1	brain:	n/a
27	chr19:43085416-43085466	PrEC	prostate:	n/a
28	chr19:43085416-43085466	AoSMC	blood vessel:	n/a
29	chr19:43085416-43085466	GM06990	blood:	n/a
30	chr19:43085416-43085466	HRCEpiC	kidney:	n/a
31	chr19:43085416-43085466	AG10803	skin:	n/a
32	chr19:43085416-43085466	SK-N-SH_RA	brain:	n/a
33	chr19:43085416-43085466	A549	lung:	n/a
34	chr19:43085416-43085466	BE2_C	brain:	n/a
35	chr19:43085416-43085466	HepG2	liver:	n/a
36	chr19:43085416-43085466	SK-N-SH	brain:	n/a
37	chr19:43085416-43085466	ovcar-3	ovarian:	n/a
38	chr19:43085416-43085466	PANC-1	pancreas:	n/a
39	chr19:43085416-43085466	ECC-1	luminal epithelium:	n/a
40	chr19:43085416-43085466	HAEpiC	amniotic membrane:	n/a
41	chr19:43085416-43085466	SK-N-MC	brain:	n/a
42	chr19:43085416-43085466	K562	blood:	n/a
43	chr19:43085416-43085466	T-47D	breast:	n/a
44	chr19:43085416-43085466	HL-60	blood:	n/a
45	chr19:43085416-43085466	HCPEpiC	choroid plexus:	n/a
46	chr19:43085416-43085466	AG04449	skin:	fetal
47	chr19:43085416-43085466	IMR90	lung:	fetal
48	chr19:43085416-43085466	HIPEpiC	eye:	n/a
49	chr19:43085416-43085466	HEEpiC	esophagus:	n/a
50	chr19:43085416-43085466	LNCaP	prostate:	n/a

No.	Distal block	Cell Line	Cell type
1	chr19:43068025..43070729-chr19:43097303..43100270,2	MCF-7	breast:
2	chr19:43070688..43071772-chr19:43100056..43100921,4	MCF-7	breast:
3	chr19:43092830..43095599-chr19:43097248..43100120,2	K562	blood:
4	chr19:43068393..43071134-chr19:43075524..43077066,2	MCF-7	breast:
5	chr19:43086009..43087735-chr19:43091658..43093226,2	MCF-7	breast:
6	chr19:43067242..43067993-chr19:43100482..43101078,2	MCF-7	breast:
7	chr19:43086009..43087735-chr19:43091658..43093226,2	MCF-7	breast:
8	chr19:43070787..43071783-chr19:43100383..43100953,3	MCF-7	breast:
9	chr19:42965246..42967758-chr19:43079335..43081443,2	MCF-7	breast:
10	chr19:43068393..43071134-chr19:43075524..43077066,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CEACAM8-1	chr19:43065825-43065902	NONHSAT066563

Variant related genes	Relation type
CEACAM1	TF binding region
CEACAMP2	TF binding region
CEACAM1	CpG island
CEACAMP2	CpG island
ENSG00000124469	chromatin interactions

Extended variants
information (count: 1126 )
Associated
traits (count: 63 )

Variant overlapped rSNPs/rCNVs (count:1126 , 50 per page) page: 1 2 3 4 5 6 7 ... 23

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs570181288	chr19:43065664-43065665	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs539300309	chr19:43065716-43065717	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs558999796	chr19:43065730-43065731	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs577537319	chr19:43065735-43065736	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs533772410	chr19:43065808-43065809	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs553860691	chr19:43065827-43065828	Weak transcription Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
7	rs573769756	chr19:43065874-43065875	Weak transcription Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
8	rs542792280	chr19:43065892-43065893	Weak transcription Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
9	rs10407576	chr19:43065947-43065948	Weak transcription Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs186573355	chr19:43065956-43065957	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
11	rs576708099	chr19:43065990-43065991	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs12461854	chr19:43066010-43066011	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
13	rs565057661	chr19:43066063-43066064	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
14	rs141960701	chr19:43066082-43066083	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
15	rs527634530	chr19:43066096-43066097	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
16	rs541038572	chr19:43066107-43066108	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
17	rs10469285	chr19:43066120-43066121	Weak transcription Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
18	rs144375740	chr19:43066146-43066147	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
19	rs538506753	chr19:43066180-43066181	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs570195110	chr19:43066187-43066188	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs532617486	chr19:43066227-43066228	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs552789889	chr19:43066236-43066237	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs376543563	chr19:43066292-43066293	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs192631365	chr19:43066340-43066341	Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
25	rs535379423	chr19:43066376-43066377	Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs148774845	chr19:43066394-43066395	Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs10469271	chr19:43066412-43066413	Weak transcription	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
28	rs536337804	chr19:43066444-43066445	Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
29	rs528175068	chr19:43066445-43066446	Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs185626675	chr19:43066448-43066449	Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs373165523	chr19:43066492-43066493	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs28588100	chr19:43066548-43066549	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs28473486	chr19:43066564-43066565	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs558777879	chr19:43066597-43066598	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs28566800	chr19:43066628-43066629	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs10469286	chr19:43066663-43066664	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs578131039	chr19:43066669-43066670	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs560929444	chr19:43066709-43066710	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs530048571	chr19:43066755-43066756	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs188952123	chr19:43066920-43066921	Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs563633483	chr19:43066957-43066958	Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs532698640	chr19:43066989-43066990	Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs61235204	chr19:43067053-43067054	Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
44	rs16980938	chr19:43067094-43067095	Weak transcription	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs140031205	chr19:43067112-43067113	Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs192912683	chr19:43067152-43067153	Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
47	rs113793867	chr19:43067174-43067175	Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
48	rs567237089	chr19:43067210-43067211	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
49	rs112644507	chr19:43067244-43067245	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
50	rs59889255	chr19:43067246-43067247	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:63)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Ovarian cancer	22174824	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Breast cancer	21509527	CNVD

Chromatin state (count:150 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:43050600-43067800	Weak transcription	Right Atrium	heart
2	chr19:43060200-43067600	Weak transcription	Adipose Nuclei	Adipose
3	chr19:43064000-43066200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr19:43064200-43066400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
5	chr19:43064400-43065800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
6	chr19:43064600-43065800	Bivalent Enhancer	HepG2	liver
7	chr19:43064600-43067600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
8	chr19:43064800-43070600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
9	chr19:43066000-43066200	Enhancers	iPS-18 Cell Line	embryonic stem cell
10	chr19:43066200-43066400	Enhancers	ES-I3 Cell Line	embryonic stem cell
11	chr19:43066400-43067800	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
12	chr19:43066600-43067800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
13	chr19:43067200-43069200	Enhancers	Brain Hippocampus Middle	brain
14	chr19:43067400-43067600	Enhancers	Duodenum Smooth Muscle	Duodenum
15	chr19:43067400-43071800	Enhancers	Skeletal Muscle Female	skeletal muscle
16	chr19:43067400-43072000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr19:43067400-43072000	Enhancers	Primary neutrophils fromperipheralblood	blood
18	chr19:43067600-43068000	Enhancers	Primary B cells from peripheral blood	blood
19	chr19:43067600-43068000	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
20	chr19:43067600-43068400	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
21	chr19:43067600-43068600	Enhancers	Brain Substantia Nigra	brain
22	chr19:43067600-43071400	Enhancers	Adipose Nuclei	Adipose
23	chr19:43067800-43068000	Enhancers	ES-I3 Cell Line	embryonic stem cell
24	chr19:43067800-43068000	Enhancers	iPS-15b Cell Line	embryonic stem cell
25	chr19:43067800-43068400	Enhancers	Brain Angular Gyrus	brain
26	chr19:43067800-43068400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
27	chr19:43067800-43068400	Enhancers	Stomach Smooth Muscle	stomach
28	chr19:43067800-43068600	Enhancers	Brain Inferior Temporal Lobe	brain
29	chr19:43067800-43068600	Enhancers	Right Atrium	heart
30	chr19:43067800-43069200	Weak transcription	Duodenum Smooth Muscle	Duodenum
31	chr19:43067800-43069800	Enhancers	Primary hematopoietic stem cells short term culture	blood
32	chr19:43067800-43069800	Enhancers	Skeletal Muscle Male	skeletal muscle
33	chr19:43067800-43070000	Enhancers	Fetal Muscle Leg	muscle
34	chr19:43068000-43068600	Enhancers	Fetal Heart	heart
35	chr19:43068000-43070800	Weak transcription	Primary B cells from peripheral blood	blood
36	chr19:43068000-43071000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
37	chr19:43068200-43068400	Enhancers	Aorta	Aorta
38	chr19:43068200-43068600	Enhancers	Right Ventricle	heart
39	chr19:43068200-43068800	Enhancers	Left Ventricle	heart
40	chr19:43068200-43069000	Enhancers	HSMMtube	muscle
41	chr19:43068200-43069200	Enhancers	Fetal Muscle Trunk	muscle
42	chr19:43068600-43068800	Enhancers	Primary B cells from cord blood	blood
43	chr19:43068600-43071000	Weak transcription	Brain Substantia Nigra	brain
44	chr19:43068800-43070000	Enhancers	Primary monocytes fromperipheralblood	blood
45	chr19:43068800-43071000	Weak transcription	Primary B cells from cord blood	blood
46	chr19:43069000-43069200	Enhancers	Primary hematopoietic stem cells	blood
47	chr19:43069000-43069400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr19:43069200-43069800	Enhancers	Duodenum Smooth Muscle	Duodenum
49	chr19:43069200-43071000	Weak transcription	Primary hematopoietic stem cells	blood
50	chr19:43069400-43069800	Enhancers	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links